SpectraScience Inc. announced that it has received regulatory approval for the WavSTAT4 Optical Biopsy System in Saudi Arabia. This approval will result in the delivery of a Marketing Authorization license, which is the first step in selling the technology to hospitals and physicians in the Kingdom of Saudi Arabia.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.97K | |
+12.74% | 229B | |
+13.83% | 195B | |
+18.47% | 142B | |
+29.14% | 109B | |
+3.19% | 64.85B | |
+19.03% | 54.33B | |
+7.04% | 52.09B | |
+10.90% | 45.15B | |
+4.79% | 37.39B |
- Stock Market
- Equities
- SCIE Stock
- News SpectraScience, Inc.
- SpectraScience Announces SFDA Approval in Saudi Arabia for WavSTAT4